What a buyer sees
CENTRAL PHARMACIES (UK) LIMITED
Dispensing chemist in specialised stores · Paisley · SC230534
66staff · FY2024
24years trading
—oldest owner on file
£2.4Mcash at bank
Your turnover is on public record
filed£10Mfor the year to 2024
Unusual at this size, and it works in your favour: a buyer is reading your number rather than guessing at one.
What your filings show moving
Staff66
202253 → 662024
Cash at bank£2.4M
2022£1.9M → £2.4M2024
How you sit in your trade
slowest tenth typical fastest tenth youSales per employee£153,099in the middle half
£95,753£142,090£223,271
Debtor daysdays26in the bottom quarter
263053
Creditor daysdays44
284463
Stock daysdays16in the middle half
131935
Each spread is companies in the same trade and size that did publish a turnover. Creditor days are shown but not marked: neither end of that one is plainly good.
What a buyer would ask 2
- The newest accounts on file are 29 months oldAnyone looking at the company today is reading a year that has already ended. Whatever has improved since is invisible.
- No website on file against the companyThe first thing anyone does with a company number is look for the business behind it. Finding nothing is its own answer.
What a buyer would like 4
- 24 years of trading on fileLongevity is the cheapest evidence there is that the business is not one contract.
- Headcount grew from 53 to 66Growth a buyer can verify without asking you for anything.
- Debtor days better than three quarters of your tradeYours is 26 against 30 for the middle of 33 comparable companies.
- A board that has been together ten years or moreContinuity a buyer does not have to take on trust.
What the register says
Owners
Nobody recorded with significant control.
Directors
- 66since 2002
- 54since 2002
| Year to | Turnover | Staff | Cash |
|---|---|---|---|
| 2024-03-30 | £10M | 66 | £2.4M |
| 2023-03-30 | not filed | 53 | £2.2M |
| 2022-03-30 | not filed | 53 | £1.9M |
A rough bracket, and why it is only that
0.25–0.5× sales£2.5M£5.0M
The turnover range is fitted on UK companies that did file one. The multiple is a published sector average from Dutch mid-market deals, not from your own numbers and not from your own market. Treat this as the opening bracket of a conversation, not a valuation.